Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indofarma Tbk. (INAF) vs WIR ASIA Tbk. (WIRG) Price & Performance

Indofarma Tbk.Trade
WIR ASIA Tbk.Trade

Price performance (Past 24H)

Key statistics

Indofarma Tbk. vs WIR ASIA Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while WIR ASIA Tbk. trades at Rp77 (market cap 955.09B, 774.95M 24h volume). The key difference: WIR ASIA Tbk. is far larger — about 2.4× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.

INAFWIRG
Market Cap
390.51B955.09B
Volume
774.95M
Lot
7.75M
Turnover
61.67B
Average Price
79.57
Value
61.67B
Indicative Equilibrium Price
77
Indicative Equilibrium Volume
33.81K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INAF
View details
WIRG
View details

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF

About WIR ASIA Tbk.

PT WIR ASIA Tbk (the Company) was established on Notarial Deed No. 16 dated August 15, 2011 of Musa Muamarta, S.H. The Company started its commercial operations in 2013.

Read more on WIRG